Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) went up by 5.49% from its latest closing price when compared to the 1-year high value of $42.99 and move down -13.52%, while DCPH stocks collected +61.49% of gains with the last five trading sessions.

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Worth an Investment?

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) 9 of the analysts out of 10 who provided ratings for Deciphera Pharmaceuticals, Inc. stocks as a “buy” while 0 as overweight, 0 rated it as hold and 1 as sell. The average price we get from analysts is $55.20 which is $7.63 above current price. DCPH currently has a short float of 19.62% and public float of 15.77M with average trading volume of 438.53K shares.

DCPH Market Performance

DCPH stocks went up by 61.49% for the week, with the monthly jump of 81.11% and a quarterly performance of 61.35%, while its annual performance rate touched 7.04%. The simple moving average for the period of the last 20 days is 67.24% for DCPH stocks with the simple moving average of 57.80% for the last 200 days.

Analysts’ Opinion on Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)

Many brokerage firms have already submitted their reports for DCPH stocks, with Deutsche Bank repeating the rating for DCPH shares by setting it to “Buy”. The predicted price for DCPH socks in the upcoming period according to Deutsche Bank is $42 based on the research report published on July 18, 2019.

B. Riley FBR, on the other hand, stated in their research note that they expect to see DCPH stock at the price of $34, previously predicting the value of $27. The rating they have provided for DCPH stocks is “Buy” according to the report published on December 31, 2018.

Leerink Partners gave “Underperform” rating to DCPH stocks, setting the target price at $34 in the report published on September 25, 2018.

DCPH Stocks 66.73% Far from 50 Day Moving Average

After a stumble in the market that brought DCPH to its low price for the period of the last 52 weeks, Deciphera Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -11.91% of loss for the given period.

The stock volatility was left at 6.90%, however, within the period of a single month, the volatility rate increased by 12.55%, while the shares surge at the distance of +84.28% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +63.09% upper at the present time.

In the course of the last 5 trading sessions, DCPH went up by +61.49%, which changed the moving average for the period of 200 days to the total of +79.14% of gains for the stock in comparison to the 20-day moving average settled at $23.51. In addition, Deciphera Pharmaceuticals, Inc. saw 80.42% in overturn over the period of a single year with a tendency to cut further gains.

DCPH Stock Fundamentals

Based on Deciphera Pharmaceuticals, Inc. (DCPH), the company’s capital structure generated 4.69 points for debt to equity in total, while total debt to capital is set at the value of 4.48. Total debt to assets is settled at the value of 4.16 with long-term debt to equity ratio rests at 4.45 and long-term debt to capital is 4.25.